AVIR Green Hills Biotechnology is focused on exploratory research and product development of therapeutic strategies against viral infectious diseases and cancer with the aim to successfully market the resulting products. In exploratory research and product development, AVIR Green Hills Biotechnology is closely cooperating with national and international academic institutions and Clinics, among them the Clinics of the Medical University Vienna, and the Institute for Medical Virology at Goethe-University Frankfurt/M. For clinical trials, AVIR Green Hills Biotechnology collaborates with experienced and renowned institutions, such as the General Hospital Vienna. For phase III clinical trials, regulatory approval, marketing and sales AVIR Green Hills Biotechnology will seek strategic partnerships and cooperations with pharmaceutical or biotechnological companies. AVIR Green Hills Biotechnology protects its intellectual property by establishing patent families covering all current and future products. AVIR Green Hills Biotechnology is implementing high-quality human resources management and ensures continuous education of its personnel. Employees will partake in a stock option model.